Analysed Revive Therapeutics Ltd (RVVTF:OTCMKTS) News Sources
US FDA accepts Takeda and Protagonist’s NDA and grants priority review status for rusfertide as a potential first-in-class therapy for polycythaemia vera
Pharmabiz
GSK completes acquisition of California-based, clinical-stage biopharma company, RAPT Therapeutics
Pharmabiz
Takeda and Protagonist Announce U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Rusfertide as a Potential First-in-Class Therapy ...
Agence France-Presse
Mutares Signs Agreement to Sell inTime Group to Tawin Holdings Group as Logistics Platform Prepares for Next Growth Phase
EuropaWire
What is the current price of Revive Therapeutics Ltd (RVVTF:OTCMKTS)?
The current price of Revive Therapeutics Ltd (RVVTF:OTCMKTS) is $0.0147.
Revive Therapeutics Ltd (RVVTF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of Revive Therapeutics Ltd (RVVTF:OTCMKTS) since the previous trading day is $-0.00.
Revive Therapeutics Ltd (RVVTF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of Revive Therapeutics Ltd (RVVTF:OTCMKTS) since the previous trading day is -13.53%.
What is This Week's average sentiment score for Revive Therapeutics Ltd (RVVTF:OTCMKTS)?
This Week's average sentiment score for Revive Therapeutics Ltd (RVVTF:OTCMKTS) is 66 out of 100.
What is This Week's average sentiment for Revive Therapeutics Ltd (RVVTF:OTCMKTS)?
This Week's sentiment for Revive Therapeutics Ltd (RVVTF:OTCMKTS) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.